Granulomatous mycosis fungoides. Combination therapy with bexarotene and PUVA [Granulomatöse mycosis fungoides. Kombinationstherapie mit bexaroten und PUVA]

被引:0
|
作者
Wirtz M. [1 ]
Helbig D. [1 ,2 ]
机构
[1] Hautklinik, Universitätsklinikum Düsseldorf, 40225 Düsseldorf
[2] Hauttumorzentrum, Universitätsklinikum Düsseldorf
来源
Der Hautarzt | 2014年 / 65卷 / 4期
关键词
Diagnosis; Granulomatous infiltrates; Macules; Plaques; Treatment;
D O I
10.1007/s00105-014-2784-5
中图分类号
学科分类号
摘要
A 74-year-old male with granulomatous mycosis fungoides presented with multiple, redbrown macules and plaques up to 8 cm in diameter, just as in classical mycosis fungoides. Dermatohistopathologic findings showed extensive granulomatous infiltrates, in which clonality could be detected in various locations via T cell receptor rearrangement. Granulomatous mycosis fungoides is a very rare form of mycosis fungoides with histological resemblance to granulomatous slack skin. It shows a rather aggressive course and can be challenging to diagnose. In our case, combination treatment with bexarotene and bath PUVA, as recommended in guidelines, resulted in an impressive improvement of the skin lesions within ten weeks. © Springer-Verlag 2014.
引用
收藏
页码:274 / 276
页数:2
相关论文
共 50 条
  • [41] BULLOUS PEMPHIGOID - OCCURRENCE IN A PATIENT WITH MYCOSIS-FUNGOIDES RECEIVING PUVA AND TOPICAL NITROGEN-MUSTARD THERAPY
    PATTERSON, JW
    ALI, M
    MURRAY, JC
    HAZRA, TA
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1985, 24 (03) : 173 - 176
  • [42] RESULTS OF A PROSPECTIVE PHASE II TRIAL OF ORAL LOW DOSE BEXAROTENE AND ULTRAVIOLET A PHOTOCHEMOTHERAPY (PUVA) FOR EARLY AND ADVANCED STAGE MYCOSIS FUNGOIDES
    Rupoli, S.
    Pimpinelli, N.
    Goteri, G.
    Canafoglia, L.
    Brandozzi, G.
    Federici, I.
    Giantomassi, F.
    Micucci, G.
    Scortechini, A.
    Da Lio, L.
    Ricotti, G.
    Simonacci, M.
    Filosa, G.
    Mozzicafreddo, G.
    Leoni, P.
    HAEMATOLOGICA, 2013, 98 : 360 - 361
  • [43] Chemotherapy with Pegylated Liposomal Doxorubicin (PLD) in Combination with PUVA and Interferon-Alpha in Stage IIB Mycosis Fungoides (MF)
    Mebes, K.
    von den Driesch, P.
    AKTUELLE DERMATOLOGIE, 2006, 32 (07) : 322 - 325
  • [44] Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides
    Rupoli, Serena
    Canafoglia, Lucia
    Goteri, Gaia
    Leoni, Pietro
    Brandozzi, Giuliano
    Federici, Irene
    Micucci, Giorgia
    Giantomassi, Federica
    Mozzicafreddo, Giorgio
    Alterini, Renato
    Filosa, Giorgio
    Ricotti, Giuseppe
    Simonacci, Marco
    Scortechini, Anna Rita
    Zizzi, Antonio
    Pimpinelli, Nicola
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (01) : 13 - 20
  • [45] Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides
    Serena Rupoli
    Lucia Canafoglia
    Gaia Goteri
    Pietro Leoni
    Giuliano Brandozzi
    Irene Federici
    Giorgia Micucci
    Federica Giantomassi
    Giorgio Mozzicafreddo
    Renato Alterini
    Giorgio Filosa
    Giuseppe Ricotti
    Marco Simonacci
    Anna Rita Scortechini
    Antonio Zizzi
    Nicola Pimpinelli
    European Journal of Dermatology, 2016, 26 : 13 - 20
  • [46] A retrospective study comparing PUVA therapy with and without maintenance therapy in patients with mycosis fungoides in a real-word clinical practice
    Eberlein, Bernadette
    Frasheri, Lorenz
    Hein, Ruediger
    Posch, Christian
    Persa, Oana-Diana
    JEADV CLINICAL PRACTICE, 2025, 4 (01): : 299 - 303
  • [47] Lesional skin chemokine CTACK/CCL27 expression in mycosis fungoides and disease control by IFN-α and PUVA therapy
    Goteri, Gaia
    Rupoli, Serena
    Campanati, Anna
    Costagliola, Antonello
    Sabato, Simona
    Stramazzotti, Daniela
    Picardi, Paola
    Canafoglia, Lucia
    Pulini, Stefano
    Ganzetti, Giulia
    Offidani, Anna Maria
    Leoni, Pietro
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2009, 1 (02): : 203 - 210
  • [48] A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon α
    Rupoli, S
    Goteri, G
    Ranaldi, R
    Roberta, C
    Scortechini, AR
    Filosa, A
    Pulini, S
    Tassetti, A
    Brancorsini, D
    Giangiacomi, M
    Masia, MC
    Leoni, P
    BLOOD, 2004, 104 (11) : 893A - 893A
  • [49] Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single-center cross-sectional study
    Zengarini, Corrado
    Barufaldi, Gregorio
    Piraccini, Bianca Maria
    Bardazzi, Federico
    Mussi, Martina
    Hrvatin, Bor
    Pileri, Alessandro
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2023, 39 (05) : 435 - 440
  • [50] Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real-life experience from a single tertiary center
    Pelin, Ertop Dogan
    Akay, Bengu Nisa
    Secil, Vural
    Canan, Ari
    Tugce, Erturk Yilmaz
    Hatice, Sanli
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2023, 39 (05) : 428 - 434